Submit more data on Sputnik V: CDSCO panel to Dr Reddys Medical Dialogues Team11 April 2021 11:15 AM ISTNew Delhi: In response to an application for emergency use authorization of Russian Covid-19 vaccine Sputnik V, the Subject Expert Committee (SEC)...
Setback: DCGI rejects Dr Reddys Application For Full Marketing Of Remdesivir Ruchika Sharma3 Nov 2020 1:45 PM IST"After detailed deliberation, the committee did not recommend for grant of full marketing authorization to Dr Reddy's Labs and opined that approval...
Dr Reddys suffers cyber-attack, temporarily shuts operations across globe Ruchika Sharma23 Oct 2020 5:45 PM ISTBengaluru: In an alarming incident, the Hyderabad-based drugmaker Dr Reddy's Laboratories recently suffered a cyber attack. The firm has now isolated...
Setback to Dr Reddys: CDSCO panel rejects proposal to test Covid vaccine Sputnik-V due to inadequate data Ruchika Sharma8 Oct 2020 4:06 PM ISTThe recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from...
Dr Reddys unveils COVID-19 drug Remdesivir under brand name Redyx in India Medical Dialogues Bureau10 Sept 2020 2:16 PM IST"Dr Reddy's Redyx is available in the strength of 100 mg vial," dr Reddy's said.
Wockhardt Pharma reports net profit at Rs 760 crore in Q1 Farhat Nasim31 Aug 2020 12:59 PM ISTNew Delhi: Drug firm Wockhardt NSE -4.42 % on Saturday reported a consolidated net profit of Rs 759.75 crore for June quarter mainly on account of...
Dr Reddys Labs: USFDA closes warning letter for three sites Ruchika Sharma30 Aug 2020 10:15 AM ISTIn November 2015, Dr Reddy's had said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites --...
Dr Reddys unveils generic Ciprodex in US to treat bacterial infection Farhat Nasim11 Aug 2020 3:31 PM ISTNew Delhi: Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%)...
FY21: Dr Reddy's Q1 results to be released on July 29th Ruchika Sharma22 July 2020 9:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd. has recently said that the company will announce results for the first quarter ended June 30, 2020, on...
NPPA fixes retail price of 14 formulations; Details Farhat Nasim4 July 2020 3:36 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 10:45 AM ISTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
Dr Reddy's New drugs for pediatrics, dermatology, oncology on the anvil Farhat Nasim25 Jun 2020 12:46 PM ISTThe products' segment focuses on research and development, and commercialization of different formulations.
